MedBox, which is developing an automated dispensing machine for marijuana, has raised $2.5 million, hitting a high in financing, with individuals jointly putting in the money for this stone-cool product.
http://medcitynews.com/2014/10/biometrics-developer-cannabis-industry-medbox-raises-2-5m/?utm_source=MedCity+News+Subscribers&utm_campaign=520acf41e3-RSS_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_c05cce483a-520acf41e3-67648197In an effort to ensure that especially elderly people take their drugs as prescribed, a variety of new ways of packaging medications, including electronic devices to tell when a person has at least removed the drug from the package. A metareview in JAMA finds little strong evidence to suggest that such methods increase adherence, although certain reminder systems may have had an effect.
http://jama.jamanetwork.com/article.aspx?articleid=1906619SureScripts has substantially expanded the use of its network for electronic drug prior authorizations, signing up the two largest PBMs and several technology companies. Electronic PAs are much more common as specialty use grows.
http://www.healthdatamanagement.com/news/Surescripts-Expands-e-Prescribing-Service-Network-48838-1.html?utm_campaign=daily-sep%2022%202014&utm_medium=email&utm_source=newsletter&ET=healthdatamanagement%3Ae3096652%3A3722900a%3A&st=emailRandomized clinical trials theoretically are the most trustworthy form of research, but an article in JAMA finds that reanalyses of data from such trials often comes to a different conclusion…
Read More
E-prescribing plus formulary decision support did not have a significant effect on medication non-adherence, according to a new paper.
Read More
An Avalere analysis finds that most eligible Part D Medicare beneficiaries are not receiving medication therapy management services.
Read More
Clinverse has raised $9.5 million for its software to help make and track payments from clinical trial sponsors to investigative sites.
http://medcitynews.com/2014/08/clinverse-raises-9-1m-to-take-complexities-out-of-clinical-trial-payments/?utm_source=MedCity+News+Subscribers&utm_campaign=899c7dc55e-RSS_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_c05cce483a-899c7dc55e-67648197The FDA is issuing two guidances of interest to lab test makers, one that finalizes guidance on companion diagnostics used with certain drug treatments and one that announces FDA's intent to more comprehensively regulate "home-brew" or laboratory-developed tests, which previously had little to no scrutiny of their accuracy and reliability.
http://www.fiercemedicaldevices.com/press-releases/fda-takes-steps-help-ensure-reliability-certain-diagnostic-tests?utm_medium=nl&utm_source=internalSolvadi is the first of a new group of wonder drugs for Hepatitis C, but its cost is staggering. A brief by Milliman examines the impact of the drug on…
Read More
Studies in the Journal of the American Medical Association look at the evidence behind FDA approval of new drugs and at the reasons for delay or denials of approval.
Read More